Sanara Medtech Inc (SMTI) is a Healthcare · Medical Instruments & Supplies company listed on NASDAQ. Price $35.07 (+0.26%), Market cap $0.20B, P/E ratio 360.67, 52-week low–high $16.34 ~ $35.75.
Sanara MedTech Inc., a medical technology company, develops, markets, and distributes surgical solutions to physicians, hospitals, clinics, and post-acute care settings in the United States. The company offers CellerateRX Surgical, a medical hydrolysate of Type I bovine collagen indicated for the management of surgical, traumatic, and partial- and full-thickness wounds, as well as first- and second-degree burns. It also develops BIASURGE, a no-rinse surgical solution used for wound irrigation; FORTIFY Tissue Repair Graft(FORTIFY TRG), a freeze-dried, multi-layer small intestinal submucosa extracellular matrix sheet; BiFORM, an osteoconductive, bioactive, porous implant that allows bony ingro
Financial statements, price targets, institutional (13F) holdings and related news for Sanara Medtech Inc are updated in real time on BlackAll Trade.
Sanara Medtech Inc trades at $35.07 (+0.26%). Real-time quotes and charts are available on BlackAll Trade.
Sanara Medtech Inc has a market cap of about $0.20B. Its P/E ratio is 360.67.
Sanara MedTech Inc., a medical technology company, develops, markets, and distributes surgical solutions to physicians, hospitals, clinics, and post-acute care settings in the United States. The compa